[Molecular targeting therapy by anti-VLA-4 monoclonal antibodies for AML]

Rinsho Ketsueki. 2005 Mar;46(3):198-201.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use
  • Drug Resistance, Neoplasm / genetics
  • Drug Therapy, Combination
  • Fibronectins / metabolism
  • Gene Expression Regulation, Neoplastic
  • Genes, bcl-2
  • Humans
  • Integrin alpha4beta1 / genetics
  • Integrin alpha4beta1 / immunology*
  • Integrin alpha4beta1 / physiology
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Leukemia, Myeloid, Acute / metabolism
  • Neoplasm, Residual / drug therapy

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Fibronectins
  • Integrin alpha4beta1